Not everything in biotech has taken a hit this year. Jim Cramer spoke with the CEO of one play that has made some big leaps in both its industry and its stock, …
source CNBC
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More